ESR1 and breast carcinoma: Therefore, understanding the molecular mechanisms by which estrogen signaling regulates the proliferation and differentiation of these ERα+ luminal progenitors and how enhanced activation of estrogen–ERα signaling can lead to breast cancer is likely to be of value in the early detection of ER+ breast cancers or even in the development of preventative measures.